Tezepelumab for Nasal Polyps in Chinese Adults
Treatments studied
Part of Ear, nose & throat, Immune system & allergy clinical trials.
This study tests whether tezepelumab, a new injectable medicine, can help reduce nasal polyps and improve symptoms like nasal congestion, loss of smell, and sleep problems. You would receive the study drug while continuing your current nasal steroid spray, and your doctors would track how your symptoms change.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and weigh at least 40 kg (about 88 lbs)
- You must have been diagnosed with nasal polyps for at least 12 months and have moderate-to-severe symptoms despite current treatment
- You must have tried or been unable to use standard nasal steroid treatment, and either had sinus surgery before or taken oral/injectable steroids for polyp flare-ups in the past year
- You cannot have certain lung diseases, active infections, or uncontrolled health conditions that could affect the study results
- If you are a woman who can become pregnant, you must use reliable birth control during the study and for 16 weeks after your last injection
- You cannot take certain other biologic medicines, immunosuppressive drugs, or live vaccines during the study period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well tezepelumab, a new biologic medicine, works in real life for adults with chronic sinusitis and nasal polyps. It may help reduce symptoms like congestion and runny nose, and improve quality of life.
This trial tests a new biologic drug (tezepelumab) to see if it improves symptoms in people with both chronic sinusitis with nasal polyps and severe asthma. The goal is to reduce inflammation and help you breathe better. Participants must not have had prior sinus surgery.
This study looks at why some people with severe chronic nasal polyps respond better to mepolizumab. It may help doctors predict who will benefit from the medicine, and who may need a different plan.
This trial tests a new antibody medicine (CM326) for people with chronic sinusitis and nasal polyps whose symptoms persist despite standard treatments like nasal sprays. It aims to see if the drug can reduce inflammation and improve symptoms.
This trial tests a new injection (SHR-1905) for people with chronic sinusitis and nasal polyps who still have symptoms despite using standard nasal spray treatments. It aims to see if the drug can reduce polyp size and improve symptoms.
This study tests whether dupilumab, a medication given as an injection, helps improve the lining of the nose in people with chronic sinus inflammation and nasal polyps. If you have nasal polyps and are about to start dupilumab, or if you have sinusitis without polyps, you may be eligible to join.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.